Aurobindo Pharma Limited (APL), one of the worlds top ... As at June 13th of the year 2007 the Company unveiled their new Logo and Corporate Identity at a ceremony in Hyderabad.

Aurobindo Pharma shares traded 1% higher on Tuesday despite a slight dip in its fourth-quarter profits to ₹903 crore.

Aurobindo Pharma share price declined over 3% on Tuesday after the company reported a fire incident at one of its manufacturing facilities in Andhra Pradesh that resulted in certain ancillary ...

On the stocks to buy front, Sachin Gupta recommends Aurobindo Pharma Ltd, and Bharat Dynamics Ltd. Here's what Gupta says about the stock market. Nifty 50 rose by 0.5% today, driven primarily by ...

Aurobindo Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1196.4. The stock has experienced fluctuations today ...

Aurobindo Pharma Ltd.'s fourth-quarter profit stayed almost flat in the fourth quarter of financial year 2024-25, thereby ...

Aurobindo Pharma subsidiary CuraTeQ Biologics s.r.o. has received marketing authorisation for Zefylti, its filgrastim biosimilar version, from Medicines and Healthcare products Regulatory Agency ...

Aurobindo Pharma's Penicillin-G plant in Kakinada, operated by Lyfius Pharma, has temporarily suspended production following a fire on Sunday night. The incident, caused by self-ignition of coal ...

Shares of Aurobindo Pharma fell over 3% on April 29 after the company reported fire incident at its coal crusher area in Kakinada-based Penicillin-G Manufacturing Facility in Andhra Pradesh.

WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Lupin, Cipla, Natco Pharma, Aurobindo Pharma were down by around 2 per cent today. According to reports, the executive order signed by Trump directs the US Food and Drug Administration ...